Skip to content

TRIB

Trinity Biotech Plc

NASDAQ · Healthcare · Medical - Diagnostics & Research · IE

$6.43
−2.02%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-41.3%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION · 10 percent ownerSale65,200$52
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION · 10 percent ownerSale92,000$52
Feb 19, 2004ROBERT R MCCORMICK TRIBUNE FOUNDATION · 10 percent ownerSale17,800$52
Institutional positioning

13F filings over the trailing two quarters

New 6Increased 8Reduced 10Sold out 12
FilerActionSharesFiled
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLCIncreased661,210Jul 23, 2026
YORKVILLE ADVISORS GLOBAL, LPNew Position225,000May 13, 2026
Williams & Novak, LLCIncreased140,543Jul 8, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased76,559Aug 14, 2026
VIRTU FINANCIAL LLCNew Position26,676May 14, 2026
Moss Adams Wealth Advisors LLCUnchanged25,666Jul 27, 2026
INSPIRION WEALTH ADVISORS, LLCUnchanged25,000Jul 7, 2026
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLCReduced24,637Oct 26, 2026
Cambridge Investment Research Advisors, Inc.Unchanged22,280Jul 30, 2026
RAYMOND JAMES FINANCIAL INCUnchanged20,319Aug 14, 2026
RAYMOND JAMES FINANCIAL INCUnchanged20,319May 14, 2026
BECKER CAPITAL MANAGEMENT INCUnchanged18,000May 11, 2026
BECKER CAPITAL MANAGEMENT INCUnchanged18,000Jul 31, 2026
RENAISSANCE TECHNOLOGIES LLCReduced17,762May 14, 2026
LPL Financial LLCIncreased17,668Aug 7, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 19, 2004